11-65882514-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001335.4(CTSW):c.526G>A(p.Val176Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00051 in 1,614,216 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001335.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSW | NM_001335.4 | c.526G>A | p.Val176Ile | missense_variant | 5/10 | ENST00000307886.8 | NP_001326.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSW | ENST00000307886.8 | c.526G>A | p.Val176Ile | missense_variant | 5/10 | 1 | NM_001335.4 | ENSP00000311300 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251404Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135900
GnomAD4 exome AF: 0.000527 AC: 770AN: 1461870Hom.: 1 Cov.: 37 AF XY: 0.000513 AC XY: 373AN XY: 727242
GnomAD4 genome AF: 0.000348 AC: 53AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.526G>A (p.V176I) alteration is located in exon 5 (coding exon 5) of the CTSW gene. This alteration results from a G to A substitution at nucleotide position 526, causing the valine (V) at amino acid position 176 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at